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The FMN-heme interdomain (intraprotein) electron transfer (IET) kinetics in full length and oxygen-
ase/FMN (oxyFMN) construct of human iNOS were determined by laser ﬂash photolysis over the tem-
perature range from 283 to 304 K. An appreciable increase in the rate constant value was observed
with an increase in the temperature. Our previous viscosity study indicated that the IET process is
conformationally gated, and Eyring equation was thus used to analyze the temperature dependence
data. The obtained magnitude of activation entropy for the IET in the oxyFMN construct is only one-
ﬁfth of that for the holoenzyme. This indicates that the FMN domain in the holoenzyme needs to
sample more conformations before the IET takes place, and that the FMN domain in the oxyFMN
construct is better poised for efﬁcient IET.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nitric oxide (NO) is one of the most studied small molecules in
biology due to its involvement in numerous biological processes
such as vasodilation, neurotransmission and immune response
[1,2]. Mammalian NO synthase (NOS) catalyzes the conversion of
L-arginine (Arg) to NO with NADPH and O2 as co-substrates [3,4].
There is still much unknown about how NO production by NOS
is tightly regulated [4–6]. It is of biomedical importance to study
mechanisms of NOS regulation because unregulated NO produc-
tion by NOS has been implicated in an increasing number of
human pathologies, including cancer and ischemic injury caused
by stroke [2,7].
There are three NOS isoforms in mammals: endothelial NOS
(eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). Mamma-
lian NOS is a homodimeric ﬂavo-hemoprotein. Each NOS subunit
comprises of an N-terminal oxygenase domain (containing a
catalytic heme active site) and a C-terminal reductase domainchemical Societies. Published by E
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r electron transfer; dRF, 5-(containing FAD and FMN cofactors), with a calmodulin (CaM)
binding region between the two domains [4,5]. The substrate,
L-Arg, and a cofactor, (6R)-5,6,7,8-tetrahydrobiopterin ðH4BÞ, both
bind near the heme center in the oxygenase domain. The iNOS iso-
form binds CaM tightly while nNOS and eNOS bind CaM reversibly
in response to intracellular Ca2þ concentration [3,4]. The interdo-
main (intraprotein) electron transfer (IET) processes are key steps
in NO synthesis [3,4,8,9]. Speciﬁcally, the CaM-controlled intersub-
unit FMN-heme IET is essential in coupling electron transfer in the
reductase domain with NO synthesis in the heme domain [10]. A
laser ﬂash photolysis approach, recently developed in laboratories
of Feng and Tollin [11], has been used for direct determination of
kinetics of the IET between catalytically signiﬁcant redox couples
of FMN and heme in bi-domain oxygenase/FMN (oxyFMN) con-
structs [11–13] and full-length NOS enzymes [13,14].
It is generally accepted that CaM-binding has little effect on the
thermodynamics of redox processes in NOS [15–17], implying dy-
namic CaM regulation of IET via redox-linked conformational
changes. A FMN-domain tethered shuttle model (Fig. 1) was re-
cently proposed [18] and supported by kinetics [12,14,19,20] and
thermodynamic [21] studies. This model involves the swinging of
the FMN domain from its original electron-accepting (input) state
to a new electron-donating (output) state. The putative output
state (bottom panel of Fig. 1) is a complex between the oxygenase
and FMN domains, which favors electron output from FMN to
heme, and hence activates NO production. The output state struc-













Fig. 1. Tethered shuttle model. Flavodoxin-type FMN-binding domain (yellow)
shuttles between the ﬂavodoxin-NADPH reductase (FNR)-type ‘‘dehydrogenase
unit’’ and the heme-containing oxygenase domain. Top: input state; bottom: output
state. Free FMN domain conformations also exist in between the two docked states.
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which only consists of the heme-containing oxygenase and FMN
domains, along with the CaM-binding region [22]. This construct
is a minimal electron transfer complex designed to favor the inter-
actions between the FMN and heme domains [22].
An appreciable decrease in the FMN-heme IET rate constant va-
lue of a human iNOS oxyFMN construct was observed with an in-
crease in the solution viscosity [23]. The kinetics and NOS ﬂavin
ﬂuorescence results indicate that the FMN-heme IET in iNOS is
gated by a large conformational change, and that the docked
FMN/heme state is populated transiently [23]. In the present work,
we have investigated the temperature dependence of kinetics of
the FMN-heme IET in truncated oxyFMN and full length human
iNOS proteins. To our knowledge, this is the ﬁrst temperature-
dependence study of the NOS FMN-heme IET kinetics, which al-
lows us to directly compare the temperature-dependent behavior
of the IET process in the two protein systems.Fig. 2. Transient trace at 580 nm at 0–0.04 s obtained for [Fe(II)–CO][FMNH] form
of the human iNOS oxyFMN construct ﬂashed by 446 nm laser excitation. The
sample temperature was set at 15 C. Red trace stands for the best ﬁt using a single-
exponential decay model. Anaerobic solutions contained 10 lM iNOS oxyFMN,
20 lM dRF and 5 mM fresh semicarbazide in a pH 7.6 buffer (40 mM bis–Tris
propane, 400 mM NaCl, 2 mM L-Arg, 20 lM H4B, 1 mM Ca2þ and 10% glycerol).2. Materials and methods
2.1. Expression and puriﬁcation of human iNOS oxyFMN and
holoenzyme
The full length and oxyFMN human iNOS vectors and CaM
expression vector were generous gift from Dr. Guy Guillemette
(University of Waterloo, Canada). The iNOS plasmid was co-trans-
fected with CaM expression vector (p209) into Escherichia coli
BL21(DE3) cells by electroporation (MicroPulser, Bio-Rad). The
iNOS protein needs to be co-expressed with CaM in vitro because
of its tendency to aggregate when residues of the highly hydropho-
bic CaM-binding region are exposed to an aqueous environment.
Expression and puriﬁcation of the human iNOS proteins was per-
formed as previously described [13]. CaM binds tightly to iNOS
and co-exists in the puriﬁed iNOS proteins.
2.2. Laser ﬂash photolysis
CO photolysis experiments were conducted using an Edinburgh
LP920 laser ﬂash photolysis spectrometer, in combination with a
Q-switched Continuum Surelite I-10 Nd:YAG laser and a Contin-
uum Surelite OPO. A 446 nm laser pulse (out of the OPO module)
was focused onto the sample cell to trigger the IET reactions. A
50 W halogen lamp was used as the light source for measuring
the kinetics at ms–s time scales. A LVF-HL ﬁlter (Ocean Optics,
FL) with band pass peaked at selected wavelength (580 or
465 nm) was placed before the partially reduced protein sampleto protect it from photo-bleaching and further photo-reduction
by the white monitor beam [9]. The sample temperature was con-
trolled by using a TLC 50 cuvette holder coupled with a TC 125
temperature-controller (Quantum Northwest). Dry nitrogen gas
was purged over the cuvette surface to avoid moisture buildup at
lower temperature.
The CO photolysis experiments were performed as previously
described [11,12,14]. Brieﬂy, a CO/Ar (v/v 1:3) pre-degassed iNOS
solution was illuminated for a certain period of time to obtain a
partially reduced form of [Fe(jj)-CO][FMNH]. The sample was
subsequently ﬂashed with 446 nm laser excitation to trigger the
FMN-heme IET, which can be followed by the loss of absorbance
of FMNH at 580 nm, and the loss of absorbance of Fe(II) at
465 nm [13]. All the experiments were repeated at least twice.
The transient absorbance changes were averaged and analyzed
using OriginPro 8.5 (OriginLab).
3. Results and discussions
3.1. The FMN-heme IET kinetics in human iNOS oxyFMN as a function
of temperature
As expected, upon a 446 nm laser excitation, the absorption at
580 nm of the partially reduced human iNOS oxyFMN at 15 C de-
cays rapidly below the pre-ﬂash baseline (Fig. 2), which is due to
the FMN-heme IET (Eq. (1), where FMNhq stands for FMN hydroqui-
none), resulting in FMNH depletion [13], with a rate constant of
252.8 ± 2.2 s1.
½Fejj½FMNH ½Fejjj½FMNhq ð1Þ
This is followed by a much slower recovery toward baseline (appar-
ent rate constant = 2.5 ± 0.1 s1; Figure S1 in the Supporting Infor-
mation), which is due to CO re-binding to Fe(II) [13]. Note the
spectral ‘‘transition’’ (i.e., a reversal in direction of absorption
changes over time) in the 580 nm traces.
The IET kinetics of the oxyFMN construct was determined over
the temperature range from 283 to 304 K, and the rate constants
ket are listed in Table S1 in the Supporting Information. Note that
an appreciable increase in the IET rate constant value was observed
with an increase in the temperature. Importantly, the obtained rate
constant of the rapid decay (Fig. 2) over the temperature range is
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protein concentration, conﬁrming an intra-protein process.
3.2. The FMN-heme IET kinetics in human iNOS holoenzyme as a
function of temperature
We could hardly observe the spectral transition in the 580 nm
traces for the holoenzyme with our laser ﬂash photolysis appara-
tus. This is likely due to less sensitivity of the current setup (com-
pared to a laser ﬂash photolysis instrument in Tollin laboratory,
which allowed us to observe the IET in the holoenzyme at
580 nm [13]). Another factor could be ‘‘interference’’ from FAD in
the holoenzyme, which should not undergo IET under the experi-
mental conditions [13]. Owing to equipment sensitivity and back-
ground absorption of FAD in holo-iNOS, we need to switch to
465 nm where absorption of heme species dominates. Our previ-
ous studies clearly showed that the FMN-heme IET in iNOS can
be also monitored by absorbance decrease at 465 nm (upon laser
excitation), which is due to net oxidation of heme in Eq. (1) [13];
see Figure S2 for processes occurring in the CO photolysis experi-
ment. Indeed, using our current laser ﬂash photolysis apparatus,
we obtained the same IET rate constants for the oxyFMN construct
by measuring transient traces at 580 and 465 nm (data not shown).
The 465 nm trace has larger amplitude (compared to the 580 nm
trace), which is due to much larger absorption coefﬁcients of the
heme species than the ﬂavin species in NOS [13]. This offers an
alternative to determine the IET kinetics of NOS samples whose
IET can be barely observed at 580 nm. It is important to note that
DA465 obtained for the holo-iNOS sample on our apparatus at room
temperature of 21 C gave an IET rate constant of 34.0 ± 0.4 s1,
which is in excellent agreement with the reported value
(32 ± 3 s1) obtained for a different preparation of human iNOS
holoenzyme by using another laser ﬂash photolysis system [13].
We thus measured the IET kinetics in the holoenzyme by mon-
itoring absorption change at 465 nm. Likewise, upon CO photolysis,
the absorption at 465 nm of the partially reduced holoenzyme de-
cays below the baseline with a rate constant of 17:2 0:2 s1
(Fig. 3), followed by a slower recovery toward baseline (Figure S3).
The IET kinetics of human iNOS holoenzyme was also determined
over the temperature range from 283 to 304 K, and the rate con-
stants are listed in Table S1 in the Supporting Information.Fig. 3. Transient trace at 465 nm at 0–0.4 s obtained for the [Fe(II)-CO][FMNH]
form of the human iNOS holoenzyme ﬂashed by 446 nm laser excitation. The
sample temperature was set at 10 C. Red trace stands for the best ﬁt using a single-
exponential decay model. Anaerobic solutions contained 15 lM iNOS holoenzyme,
20 lM dRF and 5 mM fresh semicarbazide in a pH 7.6 buffer (40 mM bis–Tris
propane, 400 mM NaCl, 2 mM L-Arg, 20 lM H4B, 1 mM Ca2þ and 10% glycerol).3.3. Fit of the temperature-dependence data
Our previous viscosity study indicated that the NOS FMN-heme
IET process is conformationally gated [23]. The temperature
dependence of the IET rate constants was thus analyzed by transi-
tion state theory using the Eyring equation,
lnðk=TÞ ¼ DHz=RT þ DSz=Rþ lnðkB=hÞ ð2Þ
where DHz is the activation enthalpy, DSz is the activation entropy, h
is the Planck’s constant, kB is the Boltzmann constant, and R is the
gas constant. The obtained Eyring parameters are listed in
Table S2. Temperature dependence behaviors of gated electron
transfer processes in other proteins have been analyzed similarly
[24,25].
The best ﬁt of Eq. (2) to the oxyFMN data was realized with
DHz ¼ 52:6 3:7 kJ=mol and DSz ¼ 17:1 1:2 J=mol=K (Fig. 4).
For the holoenzyme, its activation enthalpy value (36.9 ±
1.6 kJ/mol) is a bit lower than that of oxyFMN, while its activation
entropy value (89.7 ± 4.5 J/mol/K) is about ﬁve times of the oxy-
FMN. This clearly indicates that the FMN domain in oxyFMN con-
struct is better poised for efﬁcient IET (which is consistent with
the fact that the oxyFMN construct is designed to favor the interac-
tions between the FMN and heme domains [22]). It is of note that
the obtained activation values are comparable to those of inter-ﬂa-
vin electron transfer in human cytochrome P450 reductase [25],
which is homologous to NOS reductase domain.
During NOS catalysis, the FMN domain cycles between interac-
tion with an NADPH/FAD domain (to receive electrons) and inter-
action with an oxygenase domain (to deliver electrons to the
NOS heme). In NOS holoenzyme, the FMN domain exists in two dis-
tinct docked states and other free states (Fig. 1). Recent kinetics
and ﬂuorescence results suggested that the NADPH/FAD domain
has a much greater capacity to interact with the FMN domain than
does the oxygenase domain [26]. Therefore the majority state in
the holoenzyme should be in the input state (probably because
of the inter-domain FAD/FMN interactions), which must redistrib-
ute to an IET-reactive conformation (i.e., output state) before the
IET takes place. The higher magnitude of the negative activation
entropy is consistent with the FMN-heme IET being gated by
motion of the FMN domain, which in the holoenzyme can sample
more conformations (that are not IET-competent) than in the oxy-
FMN construct.Fig. 4. Eyring plots showing the temperature dependence of ket measured for
oxyFMN (circle) and full length (triangle) human iNOS proteins. The obtained DHz
and DSz values are listed in Table S2 in Supporting Information.
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electron transfer (ET) P450 reductase protein [25], where sampling
of a continuum of conformational states gives a range of transient
donor–acceptor complexes, only a subset of which are ET-compe-
tent. The observedmonophasic kinetics in the viscosity experiment
[23] indicate that the percentile of IET-competent docked FMN/
heme conformation is small because one would expect to see bi-
phasic kinetics if the output state population is large (greater than
10% of the population). Note that there may be many docked FMN/
heme states, and not all of them are competent for the IET. The
apparent rate of heme reduction for a population of iNOS conforma-
tions could be limited by the relatively infrequent formation of the
docked IET-competent complexes. Note that the NOS heme reduc-
tion needs to be slow enough to allow the enzyme to promptly
release the NO that it makes [5]. This may explain why sampling
more conformation would be ‘‘beneﬁcial’’ to iNOS function, where
iNOS holoenzyme would have a low-frequency formation of pro-
ductive FMN/heme complexes, despite their bi-domain structure
potentially enabling amuchmore efﬁcient FMN-heme IET as occurs
in the oxyFMN construct. Another factor causing slow IET in holo-
iNOS could be slower rate of the FMN domain conformational
change step (compared to oxyFMN), which is due to additional
interactions between the FMN and NADPH/FAD domains.
We are aware that this may not be a unique explanation of the
temperature-dependence data. There are other possible explana-
tions including changes in midpoint potentials of the redox factors,
and change in the rate-limiting step for the IET [27]. Additionally,
analyses of the data with Marcus theory [28] and thermodynamic
data of the oxyFMN [22] and full length iNOS proteins [16] did not
give unreasonable values of HAB and IET distance (data not shown).
Nonetheless, in combination of recent viscosity dependence data
[23], our current gated-IET model represents a more reasonable
explanation. These results need to be extended by future thermo-
dynamic and dynamic studies, coupled with structural informa-
tion. These experiments need considerable efforts and are
outside of the scope of the present study.
In conclusion, an appreciable increase in the NOS FMN-heme
IET rate constant value was observed with an increase in the tem-
perature over the range of 283–304 K. Comparative studies of the
temperature behavior of human iNOS oxyFMN and holoenzyme
proteins, in combination with our previous viscosity dependence
results [23], indicate that the FMN domain in the holoenzyme
needs to sample more conformations before the IET takes place,
and that the FMN domain in oxyFMN construct is better poised
for efﬁcient IET.
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